HCC patients in Cluster 2 with high KPNA2, KIF2C, SPP1, and LPCAT1 expression and low FMO3 expression showed a worse survival prognosis than HCC patients in Cluster 1. This evidence concerns the gene KPNA2 and hepatocellular carcinoma.